Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Boston University
Boston University
Washington University School of Medicine
Centre Oscar Lambret
Massachusetts General Hospital
Centre Jean Perrin
Institut Paoli-Calmettes
Abramson Cancer Center at Penn Medicine
University Health Network, Toronto
Istituti Clinici Scientifici Maugeri SpA
AdventHealth
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
University of Michigan Rogel Cancer Center
Centre Hospitalier Universitaire Dijon
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
University Hospital, Montpellier
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
Assistance Publique - Hôpitaux de Paris
Nucleix Ltd.
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Institut Curie
Hospices Civils de Lyon
Jena University Hospital
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Rennes University Hospital
Assistance Publique - Hôpitaux de Paris
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Gustave Roussy, Cancer Campus, Grand Paris
University of Arkansas
IRCCS San Raffaele
Memorial Sloan Kettering Cancer Center
University of Chicago
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Mayo Clinic
Institut du Cancer de Montpellier - Val d'Aurelle
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Imperial College London
University of Virginia
Yale University